These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 206526)

  • 21. Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia.
    Tornvall P; Hamsten A; Carlson LA
    Atherosclerosis; 1990 May; 82(1-2):125-35. PubMed ID: 2360914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complexes of apo-B-containing lipoproteins and glycosaminoglycans with a density greater than 1.063 gML in the human aorta].
    Kuznetsov AS
    Vopr Med Khim; 1979; 25(3):343-8. PubMed ID: 222072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative and qualitative characterization of apolipoprotein B containing lipoproteins produced by the visceral rat yolk sac in two different in vitro systems: organ culture and isolated epithelial cells in suspension culture.
    Plonné D; Heller H; Kahlert U; Dargel R
    Biochim Biophys Acta; 1995 Apr; 1256(1):71-80. PubMed ID: 7742358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hyperlipoproteinemia in xanthomatosis.
    Hessel LW; Vermeer BJ; Polano MK; De Jonge H; De Pagter HA; Van Gent CM
    Clin Chim Acta; 1976 Jun; 69(3):405-16. PubMed ID: 181183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 26. Type III hyperlipoproteinemia: an analysis of two contemporary definitions.
    Fredrickson DS; Morganroth J; Levy RI
    Ann Intern Med; 1975 Feb; 82(2):150-7. PubMed ID: 163607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of lipoproteins using polyacrylamide gel electrophoresis and fractionated precipitation with polyanions and detergents. Use in the classification of hyperlipoproteinemias].
    Desreumaux C; Fruchart JC; Dewailly P; Jaillard J; Sezille G
    Ann Biol Clin (Paris); 1976; 34(5):309-16. PubMed ID: 189641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of lipoprotein transport.
    Brunzell JD; Chait A; Bierman EL
    Metabolism; 1978 Sep; 27(9):1109-27. PubMed ID: 210352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of Lipoprotein Subclasses by Charge Detection Mass Spectrometry.
    Lutomski CA; Gordon SM; Remaley AT; Jarrold MF
    Anal Chem; 2018 Jun; 90(11):6353-6356. PubMed ID: 29756771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein modifications with changing dietary proteins in rabbits on a high fat diet.
    Lacombe C; Nibbelink M
    Artery; 1980; 6(4):280-9. PubMed ID: 7396727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascites fluid lipoproteins in experimental nephrotic syndrome.
    Garber DW; Marsh JB
    Biochim Biophys Acta; 1988 Apr; 959(3):253-61. PubMed ID: 3355849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Discrepancy of apolipoprotein B values measured by two turbido-immunometric assays. Differences of turbido-immunometric reactivities between apolipoprotein B in VLDL and in LDL].
    Tsukamoto H; Morita N; Suzuki M; Mizoguchi K; Watanabe K; Iri H; Hata Y; Matsumoto K
    Rinsho Byori; 1989 May; 37(5):527-32. PubMed ID: 2770007
    [No Abstract]   [Full Text] [Related]  

  • 35. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K; Hellström K; Leijd B
    J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
    [No Abstract]   [Full Text] [Related]  

  • 36. Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey.
    Mahley RW; Weisgraber KH; Innerarity T
    Biochemistry; 1976 Jul; 15(14):2979-85. PubMed ID: 182200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis by titrimetry and electron microscopy of the molecular structure of lipoproteins, after enzymatic digestion].
    Haddam R; Helio R; Dervichian DG
    Biochimie; 1974; 56(2):255-62. PubMed ID: 4135833
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis.
    Camejo G; Riera G; Lee M; López F
    Biomed Biochim Acta; 1988; 47(3):239-45. PubMed ID: 3178789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient electroblotting of human very-low-density lipoproteins and low-density lipoproteins from composite gradient gels to nylon membranes.
    Lee LT; Wong L; Roheim PS; Thompson JJ
    Anal Biochem; 1989 Aug; 180(2):358-61. PubMed ID: 2817367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.